Robert W. Kaminski Department of Enteric Infections, Bacterial Diseases Branch Walter Reed Army Institute of Research Biography Publications Institution JoVE Articles Robert W. Kaminski has not added a biography. If you are Robert W. Kaminski and would like to personalize this page please email our Author Liaison for assistance. Publications A Phase I Trial to Evaluate the Safety and Immunogenicity of WRSs2 and WRSs3; Two Live Oral Candidate Vaccines Against Shigella Sonnei Vaccine. 08, 2018 | Pubmed ID: 30037478 Development, Interlaboratory Evaluations, and Application of a Simple, High-Throughput Serum Bactericidal Assay MSphere. 06, 2018 | Pubmed ID: 29898979 Assembly, Biochemical Characterization, Immunogenicity, Adjuvanticity, and Efficacy of Artificial Invaplex MSphere. Mar-Apr, 2018 | Pubmed ID: 29600284 Clinical Endpoints in the Controlled Human Challenge Model for Shigella: A Call for Standardization and the Development of a Disease Severity Score PloS One. 2018 | Pubmed ID: 29590182 Improving Chances for Successful Clinical Outcomes with Better Preclinical Models Vaccine. 12, 2017 | Pubmed ID: 28890194 Safety and Immunogenicity of a Candidate Bioconjugate Vaccine Against Shigella Flexneri 2a Administered to Healthy Adults: a Single-Blind, Randomized Phase I Study Clinical and Vaccine Immunology : CVI. Dec, 2016 | Pubmed ID: 27581434 Monoclonal Antibodies to Shigella Lipopolysaccharide Are Useful for Vaccine Production Clinical and Vaccine Immunology : CVI. 08, 2016 | Pubmed ID: 27280622 Development of an Aotus Nancymaae Model for Shigella Vaccine Immunogenicity and Efficacy Studies Infection and Immunity. May, 2014 | Pubmed ID: 24595138 Multiplexed Immunoassay to Assess Shigella-specific Antibody Responses Journal of Immunological Methods. Jul, 2013 | Pubmed ID: 23583496 Two Live Attenuated Shigella Flexneri 2a Strains WRSf2G12 and WRSf2G15: a New Combination of Gene Deletions for 2nd Generation Live Attenuated Vaccine Candidates Vaccine. Jul, 2012 | Pubmed ID: 22658966 Virulence, Inflammatory Potential, and Adaptive Immunity Induced by Shigella Flexneri MsbB Mutants Infection and Immunity. Jan, 2010 | Pubmed ID: 19884336 Inactivated and Subunit Vaccines to Prevent Shigellosis Expert Review of Vaccines. Dec, 2009 | Pubmed ID: 19943764 Mucosal Adjuvanticity of a Shigella Invasin Complex with Dna-based Vaccines Clinical and Vaccine Immunology : CVI. Apr, 2009 | Pubmed ID: 19225079 Immunogenicity and Efficacy of Highly Purified Invasin Complex Vaccine from Shigella Flexneri 2a Vaccine. Mar, 2008 | Pubmed ID: 18276045 IpaD Localizes to the Tip of the Type III Secretion System Needle of Shigella Flexneri Infection and Immunity. Aug, 2006 | Pubmed ID: 16861624 Mucosal Adjuvant Properties of the Shigella Invasin Complex Infection and Immunity. May, 2006 | Pubmed ID: 16622224 高スループット赤痢菌-特定の殺菌試験 Hailey P. Weerts1, Jigui Yu2, Robert W. Kaminski1, Moon H. Nahm2 1Department of Enteric Infections, Bacterial Diseases Branch, Walter Reed Army Institute of Research, 2University of Alabama at Birmingham JoVE 59164 Immunology and Infection
高スループット赤痢菌-特定の殺菌試験 Hailey P. Weerts1, Jigui Yu2, Robert W. Kaminski1, Moon H. Nahm2 1Department of Enteric Infections, Bacterial Diseases Branch, Walter Reed Army Institute of Research, 2University of Alabama at Birmingham JoVE 59164 Immunology and Infection
